Hervé Raoul

InstitutionEuropean Research Infrastructure on Highly Pathogenic Agents (ERINHA-AISBL)
AddressParis
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 1 Covid-19 publications, with a maximum of 1 publications in July 2021
    All Publications
    Bar chart showing 42 publications over 17 distinct years, with a maximum of 7 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Li T, Cai H, Yao H, Zhou B, Zhang N, van Vlissingen MF, Kuiken T, Han W, GeurtsvanKessel CH, Gong Y, Zhao Y, Shen Q, Qin W, Tian XX, Peng C, Lai Y, Wang Y, Hutter CAJ, Kuo SM, Bao J, Liu C, Wang Y, Richard AS, Raoul H, Lan J, Seeger MA, Cong Y, Rockx B, Wong G, Bi Y, Lavillette D, Li D. A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nat Commun. 2021 07 30; 12(1):4635. PMID: 34330908.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    2. Mateo M, Reynard S, Carnec X, Journeaux A, Baillet N, Schaeffer J, Picard C, Legras-Lachuer C, Allan R, Perthame E, Hillion KH, Pietrosemoli N, Dillies MA, Barrot L, Vallve A, Barron S, Fellmann L, Gaillard JC, Armengaud J, Carbonnelle C, Raoul H, Tangy F, Baize S. Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot. Sci Transl Med. 2019 10 02; 11(512). PMID: 31578242.
      Citations: 18     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    3. Reynard S, Journeaux A, Gloaguen E, Schaeffer J, Varet H, Pietrosemoli N, Mateo M, Baillet N, Laouenan C, Raoul H, Mullaert J, Baize S. Immune parameters and outcomes during Ebola virus disease. JCI Insight. 2019 Jan 10; 4(1). PMID: 30626757.
      Citations: 10     Fields:    
    4. Madelain V, Baize S, Jacquot F, Reynard S, Fizet A, Barron S, Solas C, Lacarelle B, Carbonnelle C, Mentré F, Raoul H, de Lamballerie X, Guedj J. Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies. Nat Commun. 2018 10 01; 9(1):4013. PMID: 30275474.
      Citations: 24     Fields:    Translation:AnimalsCells
    5. Ferraris O, Casalegno JS, Frobert E, Bouscambert Duchamp M, Valette M, Jacquot F, Raoul H, Lina B, Ottmann M. The NS Segment of H1N1pdm09 Enhances H5N1 Pathogenicity in a Mouse Model of Influenza Virus Infections. Viruses. 2018 09 17; 10(9). PMID: 30227598.
      Citations:    Fields:    Translation:AnimalsCells
    6. Romette JL, Prat CM, Gould EA, de Lamballerie X, Charrel R, Coutard B, Fooks AR, Bardsley M, Carroll M, Drosten C, Drexler JF, Günther S, Klempa B, Pinschewer D, Klimkait T, Avsic-Zupanc T, Capobianchi MR, Dicaro A, Ippolito G, Nitsche A, Koopmans M, Reusken C, Gorbalenya A, Raoul H, Bourhy H, Mettenleiter T, Reiche S, Batten C, Sabeta C, Paweska JT, Eropkin M, Zverev V, Hu Z, Mac Cullough S, Mirazimi A, Pradel F, Lieutaud P. The European Virus Archive goes global: A growing resource for research. Antiviral Res. 2018 10; 158:127-134. PMID: 30059721.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    7. Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C, Yekwa E, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Ferron F, Baize S. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins. J Virol. 2018 06 15; 92(12). PMID: 29593043.
      Citations: 12     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    8. Guedj J, Piorkowski G, Jacquot F, Madelain V, Nguyen THT, Rodallec A, Gunther S, Carbonnelle C, Mentré F, Raoul H, de Lamballerie X. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques. PLoS Med. 2018 03; 15(3):e1002535. PMID: 29584730.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    9. Madelain V, Guedj J, Mentré F, Nguyen THT, Jacquot F, Oestereich L, Kadota T, Yamada K, Taburet AM, de Lamballerie X, Raoul H. Erratum for Madelain et al., "Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses". Antimicrob Agents Chemother. 2018 01; 62(1). PMID: 29269432.
      Citations: 1     Fields:    
    10. Dowall SD, Jacquot F, Landon J, Rayner E, Hall G, Carbonnelle C, Raoul H, Pannetier D, Cameron I, Coxon R, Al Abdulla I, Hewson R, Carroll MW. Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product. Sci Rep. 2017 06 22; 7(1):4099. PMID: 28642489.
      Citations: 1     Fields:    Translation:AnimalsCells
    11. Subtil F, Delaunay C, Keita AK, Sow MS, Touré A, Leroy S, Msellati P, Magassouba N, Baize S, Raoul H, Ecochard R, Barry M, Delaporte E, Etard JF. Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea. Clin Infect Dis. 2017 Jun 15; 64(12):1788-1790. PMID: 28329169.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    12. Nguyen TH, Guedj J, Anglaret X, Laouénan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentré F. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis. 2017 02; 11(2):e0005389. PMID: 28231247.
      Citations: 47     Fields:    Translation:HumansCellsCTClinical Trials
    13. Piorkowski G, Jacquot F, Quérat G, Carbonnelle C, Pannetier D, Mentré F, Raoul H, de Lamballerie X. Implementation of a non-human primate model of Ebola disease: Infection of Mauritian cynomolgus macaques and analysis of virus populations. Antiviral Res. 2017 04; 140:95-105. PMID: 28132865.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    14. Etard JF, Sow MS, Leroy S, Touré A, Taverne B, Keita AK, Msellati P, Magassouba N, Baize S, Raoul H, Izard S, Kpamou C, March L, Savane I, Barry M, Delaporte E. Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study. Lancet Infect Dis. 2017 05; 17(5):545-552. PMID: 28094208.
      Citations: 41     Fields:    Translation:HumansCellsPHPublic Health
    15. Madelain V, Guedj J, Mentré F, Nguyen TH, Jacquot F, Oestereich L, Kadota T, Yamada K, Taburet AM, de Lamballerie X, Raoul H. Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses. Antimicrob Agents Chemother. 2017 01; 61(1). PMID: 27736754.
      Citations: 17     Fields:    Translation:AnimalsCells
    16. Keita AK, Toure A, Sow MS, Raoul H, Magassouba N, Delaporte E, Etard JF. Extraordinary long-term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health. Clin Microbiol Infect. 2017 06; 23(6):412-413. PMID: 27866862.
      Citations: 6     Fields:    Translation:HumansCells
    17. Nisii C, Vincenti D, Fusco FM, Schmidt-Chanasit J, Carbonnelle C, Raoul H, Eickmann M, Hewson R, Brave A, Nuncio S, Sanchez-Seco MP, Palyi B, Kis Z, Zange S, Nitsche A, Kurth A, Strasser M, Capobianchi MR, Ozin A, Guglielmetti P, Menel-Lemos C, Jacob D, Grunow R, Ippolito G, Di Caro A. The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency. Clin Microbiol Infect. 2017 Feb; 23(2):58-60. PMID: 27404371.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    18. Reynard O, Jacquot F, Evanno G, Mai HL, Salama A, Martinet B, Duvaux O, Bach JM, Conchon S, Judor JP, Perota A, Lagutina I, Duchi R, Lazzari G, Le Berre L, Perreault H, Lheriteau E, Raoul H, Volchkov V, Galli C, Soulillou JP. Anti-EBOV GP IgGs Lacking a1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs. PLoS One. 2016; 11(6):e0156775. PMID: 27280712.
      Citations: 2     Fields:    Translation:AnimalsCellsPHPublic Health
    19. Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Munoz VC, Doumbouya L, Harouna S, Kighoma PM, Koundouno FR, Lolamou R, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Uwamahoro MG, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, de Sainte Fare EB, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Duverger TA, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Apr; 13(4):e1002009. PMID: 27046271.
      Citations: 7     Fields:    
    20. Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Kighoma PM, Koundouno FR, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Mar; 13(3):e1001967. PMID: 26930627.
      Citations: 162     Fields:    Translation:HumansCellsCTClinical Trials
    21. van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, Lomas C, Faye O, Sall AA, Fransen K, Buyze J, Ravinetto R, Tiberghien P, Claeys Y, De Crop M, Lynen L, Bah EI, Smith PG, Delamou A, De Weggheleire A, Haba N. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med. 2016 Jan 07; 374(1):33-42. PMID: 26735992.
      Citations: 177     Fields:    Translation:HumansCellsCTClinical Trials
    22. Carroll MW, Matthews DA, Hiscox JA, Elmore MJ, Pollakis G, Rambaut A, Hewson R, García-Dorival I, Bore JA, Koundouno R, Abdellati S, Afrough B, Aiyepada J, Akhilomen P, Asogun D, Atkinson B, Badusche M, Bah A, Bate S, Baumann J, Becker D, Becker-Ziaja B, Bocquin A, Borremans B, Bosworth A, Boettcher JP, Cannas A, Carletti F, Castilletti C, Clark S, Colavita F, Diederich S, Donatus A, Duraffour S, Ehichioya D, Ellerbrok H, Fernandez-Garcia MD, Fizet A, Fleischmann E, Gryseels S, Hermelink A, Hinzmann J, Hopf-Guevara U, Ighodalo Y, Jameson L, Kelterbaum A, Kis Z, Kloth S, Kohl C, Korva M, Kraus A, Kuisma E, Kurth A, Liedigk B, Logue CH, Lüdtke A, Maes P, McCowen J, Mély S, Mertens M, Meschi S, Meyer B, Michel J, Molkenthin P, Muñoz-Fontela C, Muth D, Newman EN, Ngabo D, Oestereich L, Okosun J, Olokor T, Omiunu R, Omomoh E, Pallasch E, Pályi B, Portmann J, Pottage T, Pratt C, Priesnitz S, Quartu S, Rappe J, Repits J, Richter M, Rudolf M, Sachse A, Schmidt KM, Schudt G, Strecker T, Thom R, Thomas S, Tobin E, Tolley H, Trautner J, Vermoesen T, Vitoriano I, Wagner M, Wolff S, Yue C, Capobianchi MR, Kretschmer B, Hall Y, Kenny JG, Rickett NY, Dudas G, Coltart CE, Kerber R, Steer D, Wright C, Senyah F, Keita S, Drury P, Diallo B, de Clerck H, Van Herp M, Sprecher A, Traore A, Diakite M, Konde MK, Koivogui L, Magassouba N, Avšic-Županc T, Nitsche A, Strasser M, Ippolito G, et al. Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa. Nature. 2015 Aug 06; 524(7563):97-101. PMID: 26083749.
      Citations: 132     Fields:    Translation:HumansCellsPHPublic Health
    23. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Günther S. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014 Oct 09; 371(15):1418-25. PMID: 24738640.
      Citations: 528     Fields:    Translation:HumansCellsPHPublic Health
    24. Herbreteau CH, Jacquot F, Rith S, Vacher L, Nguyen L, Carbonnelle C, Lotteau V, Jolivet M, Raoul H, Buchy P, Saluzzo JF. Specific polyclonal F(ab')2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice. Immunotherapy. 2014; 6(6):699-708. PMID: 24673720.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    25. Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PLoS One. 2013; 8(3):e58414. PMID: 23516477.
      Citations: 24     Fields:    Translation:AnimalsCellsPHPublic Health
    26. Nisii C, Castilletti C, Raoul H, Hewson R, Brown D, Gopal R, Eickmann M, Gunther S, Mirazimi A, Koivula T, Feldmann H, Di Caro A, Capobianchi MR, Ippolito G. Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research. PLoS Pathog. 2013 Jan; 9(1):e1003105. PMID: 23349630.
      Citations: 9     Fields:    Translation:Humans
    27. Dhondt KP, Mathieu C, Chalons M, Reynaud JM, Vallve A, Raoul H, Horvat B. Type I interferon signaling protects mice from lethal henipavirus infection. J Infect Dis. 2013 Jan 01; 207(1):142-51. PMID: 23089589.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    28. Ferraris O, Escuret V, Bouscambert M, Casalegno JS, Jacquot F, Raoul H, Caro V, Valette M, Lina B, Ottmann M. H1N1 influenza A virus neuraminidase modulates infectivity in mice. Antiviral Res. 2012 Mar; 93(3):374-80. PMID: 22321413.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    29. Reynard O, Nemirov K, Page A, Mateo M, Raoul H, Weissenhorn W, Volchkov VE. Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release. J Infect Dis. 2011 Nov; 204 Suppl 3:S884-91. PMID: 21987765.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    30. Martinez MJ, Volchkova VA, Raoul H, Alazard-Dany N, Reynard O, Volchkov VE. Role of VP30 phosphorylation in the Ebola virus replication cycle. J Infect Dis. 2011 Nov; 204 Suppl 3:S934-40. PMID: 21987772.
      Citations: 22     Fields:    Translation:AnimalsCells
    31. Reynard O, Reid SP, Page A, Mateo M, Alazard-Dany N, Raoul H, Basler CF, Volchkov VE. Unconventional secretion of Ebola virus matrix protein VP40. J Infect Dis. 2011 Nov; 204 Suppl 3:S833-9. PMID: 21987759.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    32. Reynard O, Mokhonov V, Mokhonova E, Leung J, Page A, Mateo M, Pyankova O, Georges-Courbot MC, Raoul H, Khromykh AA, Volchkov VE. Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection. J Infect Dis. 2011 Nov; 204 Suppl 3:S1060-5. PMID: 21987742.
      Citations: 15     Fields:    Translation:AnimalsCells
    33. Mathieu C, Pohl C, Szecsi J, Trajkovic-Bodennec S, Devergnas S, Raoul H, Cosset FL, Gerlier D, Wild TF, Horvat B. Nipah virus uses leukocytes for efficient dissemination within a host. J Virol. 2011 Aug; 85(15):7863-71. PMID: 21593145.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    34. Ippolito G, Nisii C, Di Caro A, Brown D, Gopal R, Hewson R, Lloyd G, Gunther S, Eickmann M, Mirazimi A, Koivula T, Georges Courbot MC, Raoul H, Capobianchi MR. European perspective of 2-person rule for biosafety level 4 laboratories. Emerg Infect Dis. 2009 Nov; 15(11):1858. PMID: 19891889.
      Citations: 2     Fields:    Translation:Humans
    35. Gazin V, Kerdine S, Grillon G, Pallardy M, Raoul H. Uranium induces TNF alpha secretion and MAPK activation in a rat alveolar macrophage cell line. Toxicol Appl Pharmacol. 2004 Jan 01; 194(1):49-59. PMID: 14728979.
      Citations: 13     Fields:    Translation:AnimalsCells
    36. Blond D, Raoul H, Le Grand R, Dormont D. Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages. J Virol. 2000 Oct; 74(19):8904-12. PMID: 10982333.
      Citations: 14     Fields:    Translation:HumansCells
    37. Merat R, Raoul H, Leste-Lasserre T, Sonigo P, Pancino G. Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1. J Virol. 1999 Jul; 73(7):5698-706. PMID: 10364320.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    38. Aillet F, Masutani H, Elbim C, Raoul H, Chêne L, Nugeyre MT, Paya C, Barré-Sinoussi F, Gougerot-Pocidalo MA, Israël N. Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines. J Virol. 1998 Dec; 72(12):9698-705. PMID: 9811703.
      Citations: 27     Fields:    Translation:HumansCells
    39. Raoul H, Le Naour R, Blond D, Dormont D. HIV type 1 infection of human macrophages induces an upregulation of manganese superoxide dismutase gene that may protect cells from death. AIDS Res Hum Retroviruses. 1998 Mar 20; 14(5):427-34. PMID: 9546802.
      Citations: 5     Fields:    Translation:HumansCells
    40. Blond D, Chéret A, Raoul H, Le Grand R, Caufour P, Théodoro F, Dormont D. Nitric oxide synthesis during acute SIV mac251 infection of macaques. Res Virol. 1998 Mar-Apr; 149(2):75-86. PMID: 9602502.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    41. Le Naour R, Lussiez C, Raoul H, Mabondzo A, Dormont D. Expression of cell adhesion molecules at the surface of in vitro human immunodeficiency virus type 1-infected human monocytes: relationships with tumor necrosis factor alpha, interleukin 1beta, and interleukin 6 syntheses. AIDS Res Hum Retroviruses. 1997 Jul 01; 13(10):841-55. PMID: 9197378.
      Citations: 2     Fields:    Translation:HumansCells
    42. Mabondzo A, Le Naour R, Le Grand R, Vaslin B, Benveniste O, Cheret A, Raoul H, Romet-Lemonne JL, Dormont D. Functional consequences of macrophage infection by human immunodeficiency virus: bispecific antibody targeting of HIV-1-infected cells to Fc gamma RI expressing effector cells. J Hematother. 1995 Dec; 4(6):579-85. PMID: 8846019.
      Citations:    Fields:    Translation:HumansCells
    43. Mabondzo A, Rouvier P, Raoul H, Le Naour R, Courpotin C, Hervé F, Parnet-Mathieu F, Lasfargues G, Dormont D. Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants. Clin Exp Immunol. 1995 Dec; 102(3):476-80. PMID: 8536360.
      Citations: 3     Fields:    Translation:HumansCells
    44. Mabondzo A, Boussin F, Raoul H, Le Naour R, Gras G, Vaslin B, Bartholeyns J, Romet-Lemonne JL, Dormont D. Antibody-dependent cellular cytotoxicity and neutralization of human immunodeficiency virus type 1 by high affinity cross-linking of gp41 to human macrophage Fc IgG receptor using bispecific antibody. J Gen Virol. 1994 Jun; 75 ( Pt 6):1451-6. PMID: 8207409.
      Citations: 6     Fields:    Translation:HumansCells
    45. Raoul H, Mabondzo A, Le Naour R, Dormont D. Effect of human immunodeficiency virus type 1 (HIV-1) monocyte-derived macrophages infection on the manganous superoxide dismutase gene expression. Chem Biol Interact. 1994 Jun; 91(2-3):123-31. PMID: 8194128.
      Citations: 1     Fields:    Translation:HumansCells
    46. Le Naour R, Clayette P, Henin Y, Mabondzo A, Raoul H, Bousseau A, Dormont D. Infection of human macrophages with an endogenous tumour necrosis factor-alpha (TNF-alpha)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-alpha synthesis inhibitor RP 55778. J Gen Virol. 1994 Jun; 75 ( Pt 6):1379-88. PMID: 7515938.
      Citations: 2     Fields:    Translation:HumansCells
    47. Le Naour R, Raoul H, Mabondzo A, Henin Y, Bousseau A, Dormont D. Treatment of human monocyte-derived macrophages with a TNF alpha synthesis inhibitor prior to HIV1 infection: consequences on cytokine production and viral replication. Res Virol. 1994 May-Aug; 145(3-4):199-207. PMID: 7800946.
      Citations: 4     Fields:    Translation:HumansCells
    48. Mabondzo A, Aussage P, Bartholeyns J, Le Naour R, Raoul H, Romet-Lemonne JL, Dormont D. Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection. J Infect Dis. 1992 Jul; 166(1):93-9. PMID: 1535093.
      Citations: 5     Fields:    Translation:HumansCells
    49. Le Naour R, Raoul H, Mabondzo A, Ripoll L, Bartholeyns J, Romet-Lemonne JL, Dormont D. Functional consequences of monocyte/macrophage infection by HIV1. Res Immunol. 1992 Jan; 143(1):49-56. PMID: 1533048.
      Citations: 3     Fields:    Translation:HumansCells
    50. Mabondzo A, Le Naour R, Raoul H, Clayette P, Lafuma C, Barré-Sinoussi FC, Cayre Y, Dormont D. In vitro infection of macrophages by HIV: correlation with cellular activation, synthesis of tumour necrosis factor alpha and proteolytic activity. Res Virol. 1991 Mar-Jun; 142(2-3):205-12. PMID: 1716777.
      Citations: 2     Fields:    Translation:HumansCells